Licenses and other intellectual property rights health.

– raise substantial additional capital cost to fund operations – to obtain and maintain all necessary patents, licenses and other intellectual property rights; – demonstrate the safety and efficacy of the product candidates in all stages of development – to meet our development schedule for our product candidates, including with respect to clinical trial initiation, enrollment and completion; – meet applicable regulatory standards and receive required regulatory approvals on our anticipated schedule or – take, require our partners to meet obligations and achieve milestones under our license and other agreements – obtain and maintain collaborations with pharmaceutical partners as required, and – to produce drug candidates in commercial quantities at reasonable costs and compete successfully against other products and companies. We qualify our also 31st on the risks in our filings with the Securities and Exchange Commission, including those described in our Annual Report on Form 10-K for the year ended December 2006, on the 30th March 2007 has been filed relating discussed and included on our quarterly reports on Form 10-Q, May 2007, May 2007, August 2007 and the 7th Filed November 2007 health . We qualify our forward-looking statements by these warnings. Readers should not place undue reliance on the forward-looking statements. We assume no obligation and do not intend looking statements-looking statements.

ed drugs

In the year 2009 Editorial, Column Address provide to Medicare Bill To DME Competitive Bidding Programme retardation.

Random entries

Other entries from category "herbal medicine":